Clinical Trials Browser

Platinum-resistant Recurrent Ovarian Cancer × 1-dodecylpyridoxal × Clear all

NCT06687070 2025-02-26

APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST

Phase 1 Recruiting

GynecologicOther solid neoplasm

Platinum-resistant Recurrent Ovarian Cancer

NCT04348032 2022-03-31

APPROVE

Phase 2 Unknown

Platinum-resistant Recurrent Ovarian Cancer